- Our Services
- Platforms
- Target Solutions
- Technologies
- Service Types
- Our Science
- About Us
- Contact us
Our symposium will showcase next-generation preclinical models for oncology and immunology, including organoids, ex vivo human tissues, humanized mouse models, and other innovative approaches.
These emerging technologies and methodologies offer remarkable benefits using cutting-edge models that complement traditional preclinical approaches, providing increased accuracy, personalized insights, accelerated drug discovery, and cost-efficiency.
Bringing together researchers and industry professionals, the symposium will enable you to engage with dynamic discussions and collaborations and help drive the successful implementation of these next-generation preclinical models in oncology and immunology research and drug discovery.
Join us for a full agenda of talks from the leading researchers in this rapidly developing area, followed by an opportunity to network with your peers at a complimentary drink’s reception
Attendance for the symposium is free but space is limited. We encourage early registration.
Lunch will be served.
 |
Enhancing Drug Discovery Success with Preclinical SolutionsDavid Vallerand, PhD |
 |
Development of NK-humanized Mice Models for the In Vivo Evaluation of NK Based TherapiesCeline Nicolazzi, PhD |
 |
Predicting Safety and Efficacy of Engineered T Cells Using an Ex Vivo Human ModelEmmanuel Donnadieu, PhD |
 |
The Potential of Organ-on-chip: From Fundamental Research to Clinical ApplicationsStéphanie Descroix, PhD Maria-Carla Parrini PhD |
 |
Patient-derived Organoids and Fresh Ex Vivo Tissue Cultures as Translational Models for (Immuno)-oncology DrugNataliia Beztsinna, PhD |
 |
Genetic Diversity Enhances the Relevance of Mouse ModelsXavier Montagutelli, PhD |
 |
Lympho-epithelial Interactions in the Human IntestineLionel Le Bourhis, PhD, CCIB |
 |
Mouse Intraductal Patient-derived Xenograft (MIND-PDX) Models of Breast CancerJos Jonckers, PhD |
